Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling Pathways
Open Access
- 1 December 2010
- journal article
- research article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 285 (53), 41614-41626
- https://doi.org/10.1074/jbc.m110.153890
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Loading-related regulation of gene expression in bone in the contexts of estrogen deficiency, lack of estrogen receptor α and disuseBone, 2010
- Characterization of the Structural Features and Interactions of SclerostinJournal of Biological Chemistry, 2009
- BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathwayDevelopment, 2008
- Control of Bone Mass and Remodeling by PTH Receptor Signaling in OsteocytesPLOS ONE, 2008
- Osteocytes, mechanosensing and Wnt signalingBone, 2008
- Integrating Patterning Signals: Wnt/GSK3 Regulates the Duration of the BMP/Smad1 SignalCell, 2007
- A rapid and sensitive bioassay to measure bone morphogenetic protein activityBMC Cell Biology, 2007
- Mechanosensation and transduction in osteocytesBoneKEy Reports, 2006
- Bone Morphogenetic ProteinsGrowth Factors, 2004
- USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidneyBiochemical and Biophysical Research Communications, 2004